fleroxacin has been researched along with Pressure Ulcer in 1 studies
Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.
Pressure Ulcer: An ulceration caused by prolonged pressure on the SKIN and TISSUES when one stays in one position for a long period of time, such as lying in bed. The bony areas of the body are the most frequently affected sites which become ischemic (ISCHEMIA) under sustained and constant pressure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cutler, NR | 1 |
| Seifert, RD | 1 |
| Sramek, JJ | 1 |
| Boyd, WM | 1 |
| St Clair, P | 1 |
1 trial available for fleroxacin and Pressure Ulcer
| Article | Year |
|---|---|
Fleroxacin treatment of stage IV pressure ulcers with associated osteomyelitis.
Topics: Aged; Aged, 80 and over; Female; Fleroxacin; Humans; Male; Osteomyelitis; Pressure Ulcer | 1994 |